Re: Wells et al.: Aflibercept, Bevacizumab, or Ranibizumab for diabetic macular edema: Two-year results from a comparative effectiveness randomized clinical trial (Ophthalmology 2016;123:1351-1358)

Ophthalmology ◽  
2017 ◽  
Vol 124 (3) ◽  
pp. e25-e26 ◽  
Author(s):  
Paul Tornambe
Keyword(s):  
Clinical Trial ◽  
Macular Edema ◽  
Randomized Clinical Trial ◽  
Diabetic Macular Edema ◽  
Comparative Effectiveness

Intravitreal Injection Versus Sub-Tenon’s Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema: A Randomized Clinical Trial

2005 ◽  
Vol 46 (10) ◽  
pp. 3845 ◽  
Author(s):  
Marco A. Bonini-Filho ◽  
Rodrigo Jorge ◽  
Jose´ C. Barbosa ◽  
Daniela Calucci ◽  
Jose A. Cardillo ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Macular Edema ◽  
Randomized Clinical Trial ◽  
Intravitreal Injection ◽  
Triamcinolone Acetonide ◽  
Diabetic Macular Edema ◽  
Refractory Diabetic Macular Edema

A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema

Ophthalmology ◽  
2014 ◽  
Vol 121 (12) ◽  
pp. 2473-2481 ◽  
Author(s):  
Mark C. Gillies ◽  
Lyndell L. Lim ◽  
Anna Campain ◽  
Godfrey J. Quin ◽  
Wedad Salem ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Macular Edema ◽  
Randomized Clinical Trial ◽  
Diabetic Macular Edema ◽  
Intravitreal Bevacizumab ◽  
Intravitreal Dexamethasone
Sign in / Sign up

Export Citation Format

Share Document